New hope for chronic hives? drug tested in small trial
Symptom relief
Terminated
This study tested whether ritlecitinib, a drug already approved for another condition, could safely reduce hives and itching in people with chronic spontaneous urticaria (CSU). The trial planned to enroll adults aged 18–65 who have had hives for over six weeks. Participants would…
Phase: PHASE2 • Sponsor: Ahuva D Cices • Aim: Symptom relief
Last updated Jun 27, 2026 08:03 UTC